Key issues

Value of CROs

The Value of Clinical Research Organizations

Clinical Research Organizations (CROs) play a major role in ensuring safe, ethical clinical trials that help spur the development of new, life-saving drugs and medical devices that benefit millions of patients worldwide.  Not only that, but CROs have an enormous, positive impact on the American and global economy.

Here’s a look at just some of the ways CROs contribute to a healthier world, the drug development process, as well as a strong economy worldwide:

  • The top five therapeutic areas for CROs are: oncology, the central nervous system, infectious disease, metabolic disorders and cardiovascular disease. Vaccine development is another growing area of research for CROs.
  • In 2013, CRO industry revenue was estimated at $21.6 billion.  That number is expected to reach $23.6 billion in 2014—representing one-third of drug development spending.
  • ACRO member companies employ approximately 100,000 people worldwide and conduct more than 11,000 clinical trials in 115 countries, involving nearly two million research participants.
  • ACRO member companies have contributed to the development of all of the top 50 selling biopharmaceutical products globally.
  • Our member companies also participate in the global development of the vast majority of new treatments and therapies approved worldwide each year.

Read more about the value of CROs: